ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
Go back to ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors| Immucell Corp (NASDAQ: ICCC) | Delayed: 9.68 -0.06 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.74 | 52 Week High | $8.29 | |||
| Open | $9.63 | 52 Week Low | $4.99 | |||
| Day High | $9.83 | P/E | 121.00 | |||
| Day Low | $9.53 | EPS | $0.08 | |||
| Volume | 9,429 | |||||
